Trident Texofab Ltd (TTFL) is currently trading at 18.76 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Trident Texofab Limited is a semi‑composite textile manufacturer and trader based in Surat, Gujarat, producing home furnishing products, garments, suiting, shirting, technical textiles and polyester/polyblend fabrics; the company combines manufacturing (weaving, embroidery, digital printing, waterjet) with legacy trading operations to serve both finished and semi‑finished textile markets. Since adopting its 'Shifting Gears' strategy in FY19, Trident materially pivoted from trading to manufacturing, with manufacturing contributing 61.8% of Q3FY26 revenues and a raised annual capacity to roughly 250 lakh meters after three capex phases, indicating a deliberate structural shift to improve blended margins through higher value‑added production. Financially, Q3FY26 revenue from operations declined 19% YoY to ₹2,574.09 lakhs and quarterly EBITDA fell 29% to ₹164.50 lakhs with margins at 6.39%; however PAT grew 90% YoY to ₹57.01 lakhs and 9MFY26 PAT rose 65% YoY to ₹361.65 lakhs, reflecting stronger nine‑month profitability and lower interest burden in the quarter. The balance sheet shows a notable increase in shareholders’ funds to ₹4,723.87 lakhs in FY25 and current assets of ₹7,374.36 lakhs, signalling improved capitalization and working‑capital scale consistent with manufacturing expansion, even as the company continues to manage elevated working capital and historically significant interest costs. Management reiterates manufacturing as the core strength and intends to maintain trading at current run‑rates without further investment, highlighting a clear strategic focus on value‑added manufacturing capabilities while exposing the company to textile demand cyclicality and raw‑material price volatility.

Over the past 52 weeks, Trident Texofab Ltd has traded between a low of ₹15.25 and a high of ₹364.85. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Trident Texofab Ltd has a market capitalization of approximately 25.58. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Trident Texofab Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 121.81 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 25.58 Cr, Trident Texofab Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Trident Texofab Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Trident Texofab Ltd is 121.81. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.